Soluble vs Insoluble Fiber: The Gel-Forming Kind Lowers LDL, About 10 mg/dL in Trials. For Constipation, the Best-Tested Fiber Is Soluble Too.

Search for soluble vs insoluble fiber and you get a chart. Two columns. Soluble: dissolves in water, turns to gel, lowers cholesterol, steadies blood sugar. Insoluble: does not dissolve, adds bulk, keeps you regular. Then two lists of foods, so you can sort your shopping. Google’s AI answer draws exactly that table, with “Heart health & blood sugar” as the soluble column’s “Primary goal” and “Bowel regularity & constipation relief” as the insoluble one’s [1]. The phrase “insoluble vs soluble fiber” is searched about 33,100 times a month in the United States (from a paid keyword database, pulled 20 October 2026) [1].

Half the chart holds up. The gel-forming soluble fibers, the kind in oats, barley and psyllium, do lower LDL cholesterol, by a small amount: about 10 mg/dL in a 2023 pooling of supplement trials, against about 4 for the soluble fibers that do not gel [2]. The other half is shakier. For constipation, the fiber with the best trials behind it is psyllium, which is soluble, and wheat bran, the textbook insoluble fiber, has had very little testing in people who are actually constipated [3] [4].

Two words before the numbers. LDL is the cholesterol that guidelines and cholesterol drugs mainly target, the kind people call bad, reported in mg/dL, milligrams per decilitre, on an American lab report. Viscous means a fiber thickens into a gel in water, the way porridge goes gluey. Hold on to that word. It does more work on this page than “soluble” does.

The chart, line by line, against the trials
The chart saysWhat the trials found
Soluble fiber lowers cholesterolGel-forming soluble fibers: LDL about 9.8 mg/dL lower. Soluble fibers that do not gel: about 3.7 lower [2]
Soluble fiber steadies blood sugarGel-forming fibers, in type 2 diabetes: HbA1c about 0.6 points lower over weeks [5]
Insoluble fiber keeps you regularIn chronic constipation, one small trial of wheat bran in the 2022 pooling; the best-tested fiber was psyllium, which is soluble [3]
Sort your food by the two listsMost foods carry both kinds; oat bran need be only one-third soluble to count as oat bran under US rules [6]. One trial of whole diets: LDL 4.8% lower on the soluble foods, HDL 3.4% lower too [7]
Figures are differences against comparison groups, averaged across trials, in mg/dL for LDL. HbA1c is a blood test of roughly the past three months of blood sugar. Each row is explained, with its limits, below.

What does soluble actually mean?

It means what happened in a laboratory, not in you. The split comes from the way fiber is measured. By 1981 laboratories were weighing foods’ fiber in soluble and insoluble fractions [8]; an assay that measures the two separately was published in 1983 [9], and in 1988 thirteen laboratories tested a method for the official US body of analytical chemists that weighs a food’s fiber in two fractions, insoluble and soluble [10]. Even its authors wrote that the separate measurement “requires further study” [10].

In 2001 a panel of the US Institute of Medicine, the body that sets American nutrient intakes, looked at what the two fractions do in people. The fibers that lower cholesterol, it wrote, are “viscous dietary fibers that usually analyze as soluble”, and the ones that bulk up stool are the slowly fermented kinds that “usually analyze as insoluble” [11]. Fermented means broken down by gut bacteria. So it recommended that “the terms soluble and insoluble fiber be phased out”, replaced by the two properties that track what happens in the body: how viscous a fiber is, and how readily it is fermented [11]. Usually. That word is the whole page.

Twenty-five years on, the old words are still on the box. The US Nutrition Facts rule, in its version of 1 October 2026, still lets a food maker add a “Soluble fiber” line and an “Insoluble fiber” line under dietary fiber [12].

Does soluble fiber lower cholesterol?

Yes, a little, and how much depends on the gel. The largest pooling, published in 2023, gathered 181 randomised trials of soluble fiber supplements in what it counts as 14,505 participants [2]. A pooling is a meta-analysis, which combines trials to get one estimate. This one’s count adds up each arm of each trial with its comparison group, so a comparison group shared by several arms is counted again for each, and 29% of the trials were crossovers, in which the same people take the fiber and the comparison in turn [2]. In the 165 trials that measured LDL, with 199 comparisons and 12,773 people, LDL ended 8.3 mg/dL lower on soluble fiber than in the comparison groups; the confidence interval, the range the true average probably sits in, ran from 5.2 to 11.4 mg/dL [2]. That is a range for an average across trials, not a forecast for any one person.

Now split the comparisons the way the pooling’s authors labelled them, by whether the fiber is a gel-former. In 141 of those 199 the fiber was viscous, and LDL fell 9.8 mg/dL, with a range from 6.1 to 13.5. In the 54 comparisons of soluble fibers that do not gel, such as inulin and resistant maltodextrin, it fell 3.7 mg/dL, with a range from 0.4 to 6.9. The other four of the 199 did not record whether the fiber gels, and the biggest comparison described below is one of them. A second split in the same table, by gel and fermentation, does not add up to the first: it counts 138 gel-forming comparisons, not 141, so treat both as the paper’s labels. In its four comparisons of fibers that neither gel nor get fermented, the range ran from a fall of 10.6 to a rise of 12.3, so those trials could not tell either way [2].

Three things to know before leaning on those numbers. First, the authors graded their certainty in the LDL result very low, using GRADE, a standard system for rating how far evidence can be trusted, because the trials’ results varied far more than chance would explain and smaller trials with bigger effects looked over-represented [2]. The I-squared, the share of the spread between the trials’ results that is more than chance would produce, was 98.5% [2].

Second, before printing a pooled figure we look for the biggest study inside it. The biggest comparison in the pooling’s own table, 719 of the 14,505 people, about 5% by our arithmetic, was not a supplement: it was advice to eat more fruit, vegetables and oats, given to British men with angina in a larger heart trial, and the table does not say whether that fiber gelled, so it sits outside the 9.8 figure [2] [13]. The largest gel-forming comparison was 248 people, under 2% of the LDL analysis, by our arithmetic, so no single trial carries the result [2]. Third, these were trials of added fiber, given as powders, capsules, cereals and other fortified foods, not of the food lists [2].

An older pooling found the same thing in a different unit. In 1999 a Harvard team pooled 67 trials of oat products, psyllium, pectin and guar gum, all of them gel-forming fibers, in 2,990 people [14]. Each extra gram of soluble fiber a day went with LDL about 1.1 mg/dL lower (0.029 mmol/L) across the 55 trials that measured it, and about 2.2 mg/dL lower (0.057 mmol/L) in the 22 trials that used 2 to 10 g a day [14]. Its worked example: 3 g of soluble fiber from oats, about three 1-oz (28 g) servings of oatmeal, would lower LDL by about 5 mg/dL (0.13 mmol/L), and it concluded that soluble fiber “can make only a small contribution” to lowering cholesterol by diet [14]. A later pooling of 28 oat trials, which our oatmeal verdict reports, found about 9.7 mg/dL (0.25 mmol/L) at 3 g of oat beta-glucan a day or more. The 1999 and 2023 poolings share many of the same older trials, so the 2023 one is a bigger, newer count of much the same evidence, not a separate check.

Look at what the comparison groups were given. In 57 of the 67 trials it was a fiber low in soluble fiber, such as wheat bran, a cellulose placebo or corn flakes [14]. The insoluble fiber was the dummy. By our count of the 2023 pooling’s table, wheat bran was the comparison in 19 of its comparisons and cellulose in 21 [2]. In the study the 2001 panel cited, wheat bran had not significantly lowered blood cholesterol [11].

A Toronto group, the same one behind the blood-sugar pooling below, pooled exactly that pairing in 2023: gel-forming fibers against a fiber its authors call insoluble, mostly cereal fiber from wheat, rice or maize, and in 15 of its 89 trials cellulose, an isolated fiber. Across 80 trials and 102 comparisons, LDL ended about 10 mg/dL lower on the gel-formers (0.26 mmol/L), with a range from 8.5 to 11.6 (0.22 to 0.30), and the authors graded that evidence moderate [15]. Nearly half of those comparisons, 47 of 102, were of oat beta-glucan; neither the paper nor its supplement gives results trial by trial, so we cannot name its biggest one [15]. Industry alone funded a third of its trials, and its authors include one who previously held patents on a viscous fiber blend and one who part-owns a contract research company [15]. It shares trials with the 181-trial pooling above, the oat trial below among them, so it is the same evidence cut a third way, not a separate check [15] [2]. And because it sets a gel against a fiber that does not dissolve, it backs the chart’s cholesterol line without telling the gel apart from the solubility.

The cleanest test of the gel kept the fiber the same and changed only how thick it gets. In a 2010 trial at five centres in Canada, Australia and the UK, two of them contract research companies, 367 adults with raised LDL were assigned a breakfast cereal with wheat fiber, the comparison, or one of four oat cereals whose beta-glucan, the soluble fiber in oats, had been cut to different molecular sizes, which sets how viscous it gets [16]. After four weeks the three thicker versions had LDL 7.3 to 10.1 mg/dL lower than wheat fiber (0.19 to 0.26 mmol/L); the thinnest, at 4 g a day, 3.9 mg/dL (0.10 mmol/L), a difference within chance [16]. Same fiber, still soluble, and by the authors’ account its efficacy “was reduced by 50%”. An oat beta-glucan supplier paid for that trial and designed its cereals, the first author’s contract research company is its registered sponsor, and its four comparisons are inside the 2023 pooling above, the 181-trial one, all four of them, the thinned one included, counted there as viscous [16] [2]. So the trial does not explain that pooling’s split, and it is not a separate check on it either. What it shows is that within one fiber the gel mattered. The pooling’s “viscous” is a label for a kind of fiber, not a measured gel: the same label covers oat and barley beta-glucan cut to smaller molecules and guar gum that had been broken down [2].

The regulators drew the line in the same place. US rules let a food claim a lower risk of heart disease for soluble fiber only from named sources, whole-oat and barley beta-glucan at 3 g a day or psyllium husk at 7 g, eaten in a diet low in saturated fat and cholesterol [6]. Not soluble fiber in general. Our oatmeal verdict and our psyllium verdict rate those two on their own trials, and our foods that lower cholesterol verdict puts them beside nuts, soy and plant sterols.

Does soluble fiber steady blood sugar?

The gel-forming kinds do, in people with type 2 diabetes, and the reason again looks like the gel. In 1978 a team gave groups of four to six volunteers a 50 g glucose drink with one of several fibers and thickeners; the more viscous the additive, the more it flattened the rise in blood sugar, and guar gum lost its effect once it was broken down into a form that does not gel [17]. We read that study as its abstract.

Over weeks, a 2019 pooling from a Toronto group gathered 27 trial comparisons of viscous fiber supplements in 1,156 adults with type 2 diabetes, taken on top of their usual care [5]. HbA1c, a blood test that reflects roughly the past three months of blood sugar, was 0.61 percentage points lower than in the comparison groups, with a range from 0.29 to 0.92, in the 19 comparisons and 910 people that measured it; fasting blood sugar was about 15 mg/dL lower (0.85 mmol/L) [5]. The authors graded that evidence moderate, and the results varied a lot, with an I-squared of 91% for HbA1c [5]. Those are the corrected figures. In August 2019 the journal removed one comparison that had been counted twice and corrected the paper’s charts and its table of trials, but not its text, which still gives the earlier figures: 28 comparisons, 1,394 people and 0.58 points. We read the corrected charts in the Internet Archive’s copies; the median dose and length the text gives, about 13 g a day for eight weeks, date from before the correction [5].

Read that pooling with its ties in view. Its senior author holds patents on a viscous fiber blend for lowering blood sugar, and in its uncorrected count 12 of 28 trials did not report who paid for them [5]. Its biggest HbA1c comparison, a 2016 trial with 228 of the 910 people, counted for 6.5% of the pooled result in the corrected chart, where the weights ran from 2.4% to 6.8% and six smaller trials each counted for slightly more, so no one trial carries it; the authors report that taking out any single study did not change the result [5]. For people whose blood sugar is normal, our psyllium verdict reports no significant lowering in the pooling it read.

One finding cuts across the chart. The same Toronto authors note what they call the “strong and consistent paradoxical association”, in long studies of ordinary eaters, between non-viscous cereal fiber and whole grains and lower rates of type 2 diabetes [5]. Those studies follow people rather than assigning them anything, so they cannot show cause. But the fiber in them is not the gel-forming kind the chart files under blood sugar.

What helps you poop, soluble or insoluble fiber?

On the trials, a soluble one. The newest pooling we could read in full, from King’s College London in 2022, gathered 16 randomised trials of fiber supplements in 1,251 adults with chronic constipation, defined by symptoms such as fewer than three bowel movements a week, hard stools or straining [3]. Across the nine trials and 802 people that counted it, 66% improved on fiber against 41% on a dummy, a risk ratio of 1.48: the share improving was 48% higher [3]. A 2026 pooling of 14 trials, which we could read only as its abstract, reports the same direction [18]. That abstract also says “Soluble/fermentable fibers at >10 g/day for ≥4 weeks showed greater efficacy”; which fibers it put in that group, and which trials, the abstract does not say, and we could not read its table [18].

Which fiber did the work? Psyllium, which is soluble and forms a gel. In its three trials 1.82 times as many people improved as on the dummy, and it raised bowel movements and eased straining; the pooling’s authors call it “the most efficacious investigated fiber” [3]. The soluble fibers that do not gel, polydextrose, inulin and galacto-oligosaccharides, did not clearly raise how often people went, though inulin softened stools and caused more wind [3]. Doses above 10 g a day, taken for four weeks or more, did best [3]. One trial published after that pooling’s search, in 250 Chinese adults with functional constipation, long-standing constipation with no disease found to explain it, gave four weeks of 5 g of psyllium a day, 5 g of wheat bran with 2 g of psyllium, a fiber mix or a two-strain probiotic, each with added oligosaccharides, against a dummy of maltodextrin, a starch-derived powder [19]. How often people went rose in every arm, the dummy’s included (on the dummy, from about 3 a week to about 5.3), and no arm raised it significantly more than the dummy did [19]. Stools got softer in every active arm; compared directly with the dummy, the four-week change in stool form was significantly bigger on psyllium and on the probiotic, and just short of significance on the bran mix and the fiber mix [19]. Its psyllium sachets also held mannitol, a sugar alcohol, so that arm was not psyllium alone. Its psyllium dose was half the 10 g above which the 2022 pooling found fiber did best, and a supplement company part-funded it, supplied the sachets and employed three of its 25 authors [19].

Look inside the psyllium figure, though. Its three trials held 275 people, and 201 of them, about 73% by our arithmetic, came from one 1986 general-practice trial that lasted two weeks and compared psyllium with a powder of sugar, citric acid and undisclosed ingredients [3]. No trial in the pooling was at low risk of bias [3]. The guideline from the two big US gastroenterology societies, which pooled psyllium separately, says “only psyllium appears to be effective”, “with very limited and uncertain data on bran and inulin”, and that even psyllium’s data are of low quality [4].

And the insoluble fiber? Of the 16 trials in the 2022 pooling, one tested wheat bran: a small Italian crossover trial from 1995, in which each person took bran and a dummy for four weeks in turn, 24 people in its published summary and 29 in the reviews’ counts [3] [20]. Its summary says bran beat the dummy on how often people went and how fast food passed through, and that symptoms did not differ significantly [20]. Read by the US guideline, the gain was about 1.3 more spontaneous bowel movements a week, with a range from 1.0 fewer to 3.6 more, and the guideline rated that evidence very low [4]. One participant on bran withdrew with “unbearable” abdominal pain [3].

The British Dietetic Association’s 2025 guideline, built on the same pooling, said that with one trial no statement could be made about bran at all [21]. Its one cereal food was rye bread, which did slightly better on frequency and worse on comfort: in two trials of 48 people, six to eight slices a day for three weeks gave 0.43 more bowel movements a week than white bread, and worse overall gut symptoms [21]. Even the general advice to eat a high-fiber diet for constipation rests, by that guideline’s search, on a single randomised trial, too few for it to make a recommendation [21].

A trial that set the two kinds side by side, against a dummy, was done in irritable bowel syndrome, or IBS, a long-running mix of belly pain and disturbed bowel habit with no structural cause; more than half its patients had the constipation type [22]. In Dutch general practices, 275 adults took 10 g a day of psyllium (85 people), bran (97) or rice flour as a dummy (93) for 12 weeks [22]. In month one, 57% on psyllium reported adequate relief against 35% on the dummy; in month two, 59% against 41% [22]. Bran did not clearly beat the dummy in either month.

Month three went the other way. Bran beat the dummy, 57% against 32%, and psyllium no longer clearly did, 46% against 32% [22]. But 40% of the patients had dropped out by then, and when everyone who dropped out was counted as not relieved, bran’s month-three lead was no longer clear either [22]. Eighteen people stopped bran because they could not tolerate it, against seven on psyllium and nine on the dummy, and the authors concluded that bran should be advised “only with caution” [22]. A 2014 pooling of 14 trials in IBS, which we read as its abstract, found the benefit in the soluble-fiber trials, 17% fewer people still troubled, while bran’s 10% was within chance [23]. Its reference list includes the Dutch trial above, whose 275 patients would be about 30% of its 906 by our arithmetic, so it is partly the same evidence, not a fully separate check; we could not read its table of trials to confirm the share [23].

Where the insoluble half of the chart does have numbers is stool weight in healthy people. A 2016 review of intervention studies, sponsored by a breakfast-cereal maker that employed three of its five authors, found that each extra gram of cereal fiber a day went with about 2.2 g more stool a day, vegetable fiber about 2.0 g and fruit fiber about 0.9 g, and that the fibers gut bacteria break down least added the most, 2.9 g per gram against 0.9 [24]. More stool is not the same thing as relief from constipation, which is what the trials above measured. Our kiwi verdict covers a fruit tried against psyllium in constipation.

Is it better to take soluble fiber or insoluble fiber?

It depends what you are taking it for, and “soluble” is not quite the right word for either answer. For LDL, the trials favour the gel-forming fibers: oats, barley, psyllium and the gums [2] [14]. For chronic constipation, the best-tested supplement is psyllium, which is soluble and gel-forming, at more than 10 g a day, which the pooling’s authors judged best taken for at least four weeks [3] [21]. For IBS, psyllium again, and bran only with caution [22]. If you are not taking anything, the question mostly dissolves, because the foods carry both kinds.

Fiber supplements come with their own instructions. The US guideline notes that they are usually taken with 8 to 10 ounces of fluid, and that wind is the common side effect [4]. Psyllium sold as a laxative carries a choking warning and a note about spacing it from other medicines; our psyllium verdict quotes them. Whether fiber helps with weight is a separate question, with its own verdict.

Soluble vs insoluble fiber foods: does the list hold up?

As a rough guide, partly. In a 1993 trial, 43 adults with high blood fats, 15 men and 28 women past menopause, ate diets built from foods high in soluble fiber and diets built from foods high in insoluble fiber, four months each in random order, and their LDL was 4.8% lower on the soluble foods [7]. That is not the whole result. HDL, the cholesterol people call good, was 3.4% lower on the soluble foods too, and the ratio of total to HDL cholesterol did not differ significantly until the authors also adjusted for weight change and calories [7]. Most of the LDL difference was in the men, 9.6%; in the women it was 2.2%, a difference within chance [7]. And these were not everyday meals. Every food was packed centrally and delivered to people’s homes, both diets held more than 24 g of fiber for every 1,000 calories, nobody was blinded to which diet they were on, and the soluble side’s barley, lentils, peas, beans and oat bran came with a breakfast cereal that had psyllium, the gel-forming supplement fiber, added to it [7]. A US government heart institute and a Canadian grocery company paid for the trial, fourteen food companies donated products, the grocery company’s own-brand line among them, and one of its 16 authors was at a food company’s research centre [7]. As a sorting rule, no, because most foods carry both. Google’s own AI answer says so near its end, and puts nuts and seeds on both of its lists [1]. A probiotic seller’s blog that the answer cites lists barley, beans, lentils, apples, pears, almonds and flaxseed under both headings [1]. The US rules show it from the other side: to count as oat bran for the heart claim, at least one-third of its fiber must be soluble, which leaves up to two-thirds that is not [6].

What the lists cannot tell you is the thing that tracked the effect in the trials: whether the fiber gels, and how thick. Oat beta-glucan cut to smaller molecules was still soluble and lowered LDL half as much [16]. Its size and solubility can be changed by “normal methods of processing and storage”, the authors of that trial write [16]. A Nutrition Facts panel can give grams of soluble fiber; nothing on it says how thick that fiber gets [12].

Are chia seeds insoluble or soluble fiber?

Both, and mostly insoluble. A 2026 Scottish laboratory analysis of shop-bought chia, quinoa, pumpkin seed, flaxseed and triticale measured the main part of their fiber, the plant cell-wall carbohydrates, in soluble and insoluble fractions: insoluble predominated in all five, and chia had the most soluble fiber of the five [25]. So chia belongs on both lists, which is where most foods belong.

Do gut bacteria eat soluble or insoluble fiber?

Mostly the soluble kinds, but solubility is not the switch. The 2001 panel wrote that the fibers gut bacteria ferment slowly or not at all usually analyze as insoluble, and that most soluble fibers are “rapidly fermented” [11]. The exceptions are the interesting part. Psyllium is soluble, yet the constipation pooling’s authors describe it as resistant to fermentation and holding water instead, which is their explanation for why it softens stool [3]. Inulin is soluble and readily fermented, and in the constipation trials its fermentation showed up as wind [3]. Starch that escapes digestion is fermented too, and resistant starch has its own verdict.

Who these studies were done on

Nearly all of this evidence is supplements, not the food lists. The cholesterol pooling’s trials ran 4 to 52 weeks in adults whose average ages ranged from 26 to 67; about a quarter of the trials recruited people with high blood fats, a fifth people with type 2 diabetes, and 13% healthy people [2]. The blood-sugar pooling was adults with type 2 diabetes, median age 60 and a median of eight weeks by its uncorrected text [5]. The constipation trials ran two to eight weeks, and in the 14 that reported it, 61% to 100% of the participants were women [3]. The IBS trial was Dutch general practice, 78% women, average age 34 [22]. The stool-weight review was healthy people, 4 to 81 per study, for five days to 14 weeks [24].

So read yourself against them. If your LDL is high, these trials were about people like you, and the fall they found is small. If you have type 2 diabetes, the blood-sugar trials were about you, over weeks rather than years. If you are constipated, the trials were short and mostly in women; four of the 16 in the 2022 pooling tested psyllium, and psyllium did best. And if your question is how to sort your shopping, nearly all of these trials tested added fiber; the one trial on this page that built whole diets from the two lists measured cholesterol.

If “soluble” comes from a lab test, why does the chart get cholesterol right?

This section is the desk’s own reasoning, and it is labelled as such. The two words describe how a fiber behaves in a laboratory method. Yet the soluble column’s cholesterol line holds up, and the insoluble column’s constipation line mostly does not. Here are three ways to fit that together, each rated.

Answer one: the gel-formers happen to dissolve. The gel-forming fibers, the pectins, gums and mucilages, are soluble ones [14], but not every soluble fiber gels, and the ones that do not lowered LDL under half as much in the 181-trial pooling, 3.7 mg/dL against 9.8 [2]. Within one fiber, thinning the gel halved the effect [16]. The pooled split and the trial are measured. That the soluble label works for cholesterol only because it rides along with viscosity is the 2001 panel’s reading [11], and ours.

Answer two: the regularity column was built from stool weight, not from relief. The fibers gut bacteria break down least, which usually test as insoluble, add the most stool weight in healthy people [24] [11]. In people who are actually constipated, the 2022 pooling held one small trial of wheat bran, and in IBS bran did not clearly beat a dummy until month three [3] [22]. The weights are measured. That the chart’s constipation column was drawn from them is a surmise: we could not trace who first put the two kinds into two columns, each with a job.

Answer three: the words are on the label. The Nutrition Facts rule still offers both lines, and the heart claim is worded around “soluble fiber” [12] [6], 25 years after the 2001 panel recommended the terms be dropped [11]. Sellers sort by them too: “insoluble fiber supplement” is one of Google’s related searches, and the AI answer closes by offering to plan a “supplement routine” [1]. That a printed word outlives a recommendation to drop it is an observation from the rules and the search results, not a trial, and we mark it as one.

Put the three together and here is what we think is true, stated plainly so you can disagree with it: sort fiber by what it does in water, not by whether it dissolves; for cholesterol and blood sugar the trials keep finding the gel, and for constipation the best-tested fiber is a gel that gut bacteria leave largely alone.

What we could not find, and would like to: the bowel results of a small US trial that gave 35 people with Parkinson’s disease and constipation symptoms 10 g a day of psyllium, coarse wheat bran or a dummy for eight weeks, the same three arms as the Dutch IBS trial. Its registry record lists stool frequency and consistency among its outcomes, gives a completion date of 28 April 2024 and shows no results [26]; by 20 October 2026 we found no published report [27]. Beyond it, we would like the same three arms, with bran on its own and both fibers at more than 10 g a day, in adults with ordinary chronic constipation, run for months rather than weeks; the four-week Chinese trial above gave bran only mixed with psyllium, and at lower doses. If you know of either, the corrections line on this site is open.

Where the two-column chart came from

The split began as chemistry. By 1981 laboratories were weighing foods’ fiber in soluble and insoluble fractions, and one such paper opened by noting that certain soluble fibers lower cholesterol, then found a bigger share of soluble fiber in oats, corn and cooked beans than in wheat and green vegetables [8]. Its abstract already sets the soluble list beside the cholesterol line. An assay for the two fractions was published in 1983 [9], and when thirteen laboratories tested a method for them in 1988, its authors said the split needed more work [10]. The 1981 paper made its split by modifying an older method, which we did not read, so we cannot say when the two fractions were first measured. The framing came with the rules. A US health-claim regulation whose history begins in January 1997 lets labels link soluble fiber from named sources with a lower risk of heart disease; today it names oat and barley beta-glucan and psyllium husk [6], and the label rule offers the two lines [12]. In 2001 the Institute of Medicine’s panel recommended dropping the terms [11].

Then it spread as a chart. A US government consumer medical encyclopedia, cited by Google’s AI answer, says soluble fiber “helps lower cholesterol” and that insoluble fiber “adds bulk to the stool” [1]. The AI answer turns that into two columns with a primary goal each, adds blood sugar and constipation relief, and offers to plan a supplement routine [1].

And it sells. A probiotic seller’s blog that the AI answer cites calls insoluble fiber “The Broom of the Gut” and closes its summary by pairing both kinds with its own supplement [1]. The case against bran is made by a seller too: a 2020 review by two employees of a psyllium laxative’s maker and two academics says gel-forming psyllium was 3.4 times more effective than wheat bran at increasing stool output, and the US guideline cites it for the point that finely ground bran can harden stool; one of the review’s two academics is among the guideline’s three joint first authors [28] [4]. A seller can be right, and this one’s case matches the trials above. It is still a seller’s case, and we mark it as one.

None of this is aimed at anyone sorting their shopping by the chart. Eating both kinds is what the foods give you anyway. It is the promise that the label tells you the job that the trials did not keep.

What this is rated, and what the rating covers

Established — for the claim that gel-forming soluble fiber, the kind in oats, barley, psyllium and guar gum, lowers LDL cholesterol, by a small amount.

It is rated Established because two poolings 24 years apart, of 67 and 181 trials, found LDL lower on soluble fiber, with the gel-forming comparisons driving the larger fall [14] [2]; a 2023 pooling that set gel-formers against cereal fiber found about 10 mg/dL, graded moderate [15]; a trial that changed only the gel found the effect followed it [16]; our psyllium verdict rates psyllium Established for LDL, and our oatmeal verdict rates the oat effect Established in words, each on its own poolings; and US rules allow the heart claim for oat and barley beta-glucan and psyllium [6]. The size is the uncertain part: about 10 mg/dL in the 181-trial pooling, whose authors graded the LDL evidence very low because the trials varied so much, and in the gel-against-cereal one, graded moderate; and about 2 mg/dL per gram in the 1999 one’s practical dose range [2] [14]. These trials measured cholesterol, not heart attacks.

Each other part, rated alone, in words. That soluble fibers which do not form a gel lower LDL: Preliminary. They lowered it under half as much, in a subgroup of a pooling whose LDL evidence its authors graded very low, and the four comparisons of fibers that neither gel nor ferment could not tell a fall from a rise [2].

That gel-forming fiber steadies blood sugar: Supported in type 2 diabetes, about 0.6 points off HbA1c over weeks in a pooling graded moderate, whose senior author holds patents on a viscous fiber blend [5]. The single-meal flattening comes from small early studies [17], and the long-term claim for people without diabetes is not rated here.

That insoluble fiber relieves constipation: Preliminary. In chronic constipation, one small trial of wheat bran pointed its way, with a range that, as the US guideline read it, included no gain; the British guideline could make no statement on bran at all; and in IBS, bran did not clearly beat a dummy in the first two months, and was the one people most often stopped [3] [4] [21] [22].

That insoluble fiber adds stool bulk: Supported, in healthy people, from studies pooled by a review a cereal maker paid for, and in the 2001 panel’s account [24] [11].

That psyllium, a soluble fiber, relieves chronic constipation: Supported, on old, small trials that the guidelines rate low in certainty, with most of the people in its pooled result coming from one two-week trial in 1986 [3] [4] [21].

That a food’s place on the soluble or insoluble list tells you what it will do depends on the job, so we rate the two halves apart. For cholesterol, as a rough guide: Preliminary, in the list’s favour. In the one trial on this page that built whole diets from the two lists, LDL ended 4.8% lower on the soluble foods, but HDL was 3.4% lower too, the ratio of total to HDL cholesterol did not differ significantly in the main comparison, and the trial was 43 people on very high-fiber diets whose soluble side included oat bran and a psyllium-enriched cereal [7]. In the supplement trials the soluble fibers lowered LDL whether or not they gel, though the ones that do not gel did under half as much [2]. For constipation: Unsupported, of the tested kind. The list sends you to the insoluble side, and in the supplement trials the best-tested constipation fiber is soluble psyllium, the soluble fibers that do not gel did not clearly change how often constipated people went, and wheat bran, the classic insoluble fiber, had one small trial among the 2022 pooling’s 16 [3] [4]. As a sorting rule for whole foods it also fails for a simpler reason: most foods carry both kinds [6]. The Toronto authors’ note that long studies of ordinary eaters tie non-viscous cereal fiber and whole grains to less type 2 diabetes is an association, not a test of the list, so it is not counted here [5].

What is not rated here: weight loss, which has its own verdict; heart attacks and deaths, which the trials on this page did not measure; the individual foods, which have their own pages; and the frame above, which is this desk’s reasoning from the evidence rather than a result the evidence delivered. It is marked as ours so that you can weigh it as ours.

This is journalism, not medical advice. A sudden change in bowel habit, constipation that does not settle, or a question about taking fiber alongside a medicine belongs with a clinician or pharmacist who knows you. How we read a study, and what each tier means, is set out here.

Sources
[1] Search data from a paid keyword database: the monthly US search volume for “insoluble vs soluble fiber”, and Google’s results, People Also Ask questions, related searches and AI answer for “soluble vs insoluble fiber”, both pulled 20 October 2026. Two pages the AI answer cites, read on 20 October 2026: a US government consumer medical encyclopedia’s entry (reviewed 25 August 2026) and a probiotic seller’s blog post. Kept with this page’s records.
[2] Ghavami A, Ziaei R, Talebi S, et al. Soluble fiber supplementation and serum lipid profile: a systematic review and dose-response meta-analysis of randomized controlled trials. Advances in Nutrition 2023;14(3):465–474. 181 randomised trials, 14,505 participants as it counts them (a control group shared by several arms is counted for each); searched to November 2021. Read in full on PubMed Central, with its supplementary tables (the subgroup results by viscosity and the table of included trials) from PubMed Central’s open-data store. The paper states that no funding was received; its disclosures name support from an Iranian university of medical sciences and no financial relationship with any organisation with an interest; all authors give universities. doi:10.1016/j.advnut.2023.01.005
[3] van der Schoot A, Drysdale C, Whelan K, Dimidi E. The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 2022;116(4):953–969. 16 randomised trials, 1,251 adults; searched to March 2022. Read in full on PubMed Central. Part of a project funded by a British Dietetic Association trust fund, which had no role in the review; the journal’s funding record for it also lists an almond growers’ board and a national health research institute, and the 2025 British guideline says its first author is now funded by a grant from that almond board; two authors report grants or consulting from an almond growers’ board, a nut trade council, a plant-milk maker, a food company’s research arm, a prebiotic maker, a dairy and food company and a bakery-ingredients company. doi:10.1093/ajcn/nqac184
[4] Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association–American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation. Gastroenterology 2023;164(7):1086–1106. Read in full on PubMed Central. Wholly funded by the two societies with no support from industry, by its own statement; panel members’ industry ties were disclosed, and members with a conflict on a treatment were kept off its subcommittee. doi:10.1053/j.gastro.2023.03.214
[5] Jovanovski E, Khayyat R, Zurbau A, et al. Should viscous fiber supplements be considered in diabetes control? Results from a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 2019;42(5):755–766, with an erratum (2019;42(8):1604, doi:10.2337/dc19-er08a) that removed one duplicated comparison and corrected the figures and the table of trials, changing no conclusion by the authors’ account; the text was not corrected. 27 trial comparisons, 1,156 adults with type 2 diabetes, by the corrected figures (28 and 1,394 in the text). Read in full in the Internet Archive’s copy of the journal’s page (August 2020), which carries the correction notice, and the corrected figures in the Archive’s copies of December 2021; the journal’s own page served a bot check, and its table of included trials, a pop-up, was not saved by the Archive, so we did not read it. Its funding and duality statement names no grant for the study; it lists scholarships and awards held by authors, among them a Saudi government scholarship and a Canadian government health research institute’s prize, and PubMed’s index lists a Canadian government grant. The senior author holds Canadian and US patents on a viscous fibre blend for lowering blood sugar; one author part-owns a contract research company; another reports research support and fees from food and drink companies and trade groups, and a spouse employed by a consumer-goods company; another, fees from drug makers. doi:10.2337/dc18-1126
[6] US Code of Federal Regulations, 21 CFR 101.81, health claims: soluble fiber from certain foods and risk of coronary heart disease. Its history notes begin on 23 January 1997. Read in full in the government’s electronic edition, version of 1 October 2026, on 20 October 2026. A regulation; no DOI.
[7] Jenkins DJ, Wolever TM, Rao AV, et al. Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. New England Journal of Medicine 1993;329(1):21–26. 43 adults with high blood fats, 15 men and 28 women past menopause; a randomised crossover of two four-month metabolic diets, not blinded. Read in full in the Internet Archive’s copy of the journal’s page (July 2025). Supported by a US government heart institute grant and a Canadian grocery company; fourteen food companies, the grocery company’s own-brand line among them, donated products; one of the 16 authors gives a food company’s research centre as their affiliation. doi:10.1056/NEJM199307013290104
[8] Chen WJ, Anderson JW. Soluble and insoluble plant fiber in selected cereals and vegetables. American Journal of Clinical Nutrition 1981;34(6):1077–1082. A laboratory analysis. Read as its published abstract: the Internet Archive’s copy of the journal’s page holds only the abstract, and no open copy was listed. Its funding statement was not read; PubMed’s index lists a US government grant. doi:10.1093/ajcn/34.6.1077
[9] Asp NG, Johansson CG, Hallmer H, Siljeström M. Rapid enzymatic assay of insoluble and soluble dietary fiber. Journal of Agricultural and Food Chemistry 1983;31(3):476–482. Read as its title and bibliographic record only: PubMed and Europe PMC hold no abstract for it, and its funding statement was not read. doi:10.1021/jf00117a003
[10] Prosky L, Asp NG, Schweizer TF, DeVries JW, Furda I. Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. Journal of the Association of Official Analytical Chemists 1988;71(5):1017–1023. Thirteen laboratories. Read as its published abstract; its funding statement was not read. PubMed 2853153; no DOI.
[11] Institute of Medicine, Panel on the Definition of Dietary Fiber. Dietary Reference Intakes: Proposed Definition of Dietary Fiber. Washington, DC: National Academy Press, 2001. Read in the Internet Archive’s copies (January and March 2022) of the publisher’s online chapters, whose current pages load their text by script. Supported by Health Canada and the US Department of Health and Human Services, with a private foundation fund that included a yogurt maker’s institute and an industry-funded science body, and a corporate donors’ fund of food, confectionery, infant-formula and vitamin makers; the report says its conclusions are the committee’s own. doi:10.17226/10161
[12] US Code of Federal Regulations, 21 CFR 101.9(c)(6)(i)(A) and (B): the Nutrition Facts lines “Soluble fiber” and “Insoluble fiber”, both voluntary unless a label makes a claim about them. Read in full in the government’s electronic edition, version of 1 October 2026, on 20 October 2026. A regulation; no DOI.
[13] Ashfield-Watt PA, Clark ZE, Breay P, et al. Nutritional advice to increase soluble fibre intake does not change plasma folate or homocysteine in men with angina: a randomised controlled trial. Public Health Nutrition 2002;5(1):47–53. 753 men with angina, part of a larger heart trial. Read as its published abstract, which reports folate and homocysteine, not blood fats; its funding statement was not read. doi:10.1079/PHN2001250
[14] Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. American Journal of Clinical Nutrition 1999;69(1):30–42. 67 trials of oat products, psyllium, pectin and guar gum, 2,990 people. Read in full in the Internet Archive’s copy of the journal’s PDF (June 2017). The paper lists its trials only by fibre and does not give each trial’s size. We found no funding statement in it; its authors were at a US school of public health and its hospital, and one unpublished trial in it was provided by an oat-cereal company. doi:10.1093/ajcn/69.1.30
[15] Jovanovski E, Nguyen M, Kurahashi Y, et al. Are all fibres created equal with respect to lipid lowering? Comparing the effect of viscous dietary fibre to non-viscous fibre from cereal sources: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition 2023;129(7):1180–1192. 89 randomised trials, 4,755 people; for LDL, 80 trials and 102 comparisons; searched to October 2021. Read in full on the journal’s page, with its summary of trials by fiber type and its chart of LDL results by fiber, and its supplement, which names no trial; neither gives results trial by trial. The comparison was wheat in 52 of the 89 trials, rice in 10, cellulose in 15, maize in 5 and other cereal or starch in 7, by its summary table. We found no statement in it of who paid for the review itself. One author previously held patents on a viscous fiber blend; one part-owns a contract research company; one reports research support, food donations and fees from food companies and trade bodies, among them a nut council’s foundation, US soy and honey boards and an oat company’s research centre, and a spouse employed by a brewer; a fourth reports research support from a Canadian government health research institute, an international life-sciences institute and the US honey board. Industry alone funded a third of its trials. doi:10.1017/S0007114522002355
[16] Wolever TMS, Tosh SM, Gibbs AL, et al. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. American Journal of Clinical Nutrition 2010;92(4):723–732. 367 adults enrolled, 345 completed, four weeks, five centres in Canada, Australia and the UK, two of them contract research companies; registered as NCT00981981. Read in full in the Internet Archive’s copy of the journal’s page (October 2017). Supported by an oat beta-glucan supplier, which employed one author and designed the trial’s cereals, and by Swedish and Canadian government agencies; the first author is president of a contract research company, which the trial’s registry record names as its lead sponsor, and another author works for a second contract research company. doi:10.3945/ajcn.2010.29174
[17] Jenkins DJ, Wolever TM, Leeds AR, et al. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. British Medical Journal 1978;1(6124):1392–1394. Groups of four to six volunteers. Read as its published abstract; PubMed Central holds it only as a scanned image. Its funding statement was not read. doi:10.1136/bmj.1.6124.1392
[18] Wang Y, Yan Q, Liu F, Song Z, Song N. The impact of dietary fiber supplementation on gut-brain axis biomarkers and symptoms in functional constipation: a meta-analysis of randomized controlled trials. Clinical and Translational Gastroenterology, published ahead of print 5 October 2026. 14 randomised trials, 1,284 people; searched to January 2026. Read as its published abstract: Europe PMC holds no full text and the journal’s page showed only the abstract; its table of included trials and its funding statement were not read. doi:10.14309/ctg.0000000000001114
[19] Lai H, Li Y, He Y, et al. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut Microbes 2023;15(1):2197837. 250 adults, four weeks; registered as NCT04667884. Read in full on PubMed Central. Supported by a Chinese university, Chinese government science funds and a supplement company’s research foundation; the supplement company prepared and supplied the sachets, and three of the 25 authors give its nutrition institute as their affiliation. doi:10.1080/19490976.2023.2197837
[20] Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation: a double-blind controlled trial. Digestive Diseases and Sciences 1995;40(2):349–356. Read as its published abstract, which gives 24 patients randomised; the two reviews that pool it count 29. Its funding statement was not read. doi:10.1007/BF02065421
[21] Dimidi E, van der Schoot A, Barrett K, et al. British Dietetic Association guidelines for the dietary management of chronic constipation in adults. Journal of Human Nutrition and Dietetics 2025;38(5):e70133. Four systematic reviews, 75 trials. Read in full on PubMed Central. Funded by the association’s trust fund; authors report grants, fees or consulting from an almond growers’ board, a nut trade council, a plant-milk maker, a food company’s research arm, a bakery-ingredients company, a dairy and food company, a probiotic drink maker, prebiotic and probiotic brands and drug makers. doi:10.1111/jhn.70133
[22] Bijkerk CJ, de Wit NJ, Muris JW, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009;339:b3154. 275 adults; registered as NCT00189033. Read in full on PubMed Central. Funded by the Netherlands’ government health research organisation; the psyllium was supplied by a drug company; the sponsors had no role, and the authors declare no competing interests. doi:10.1136/bmj.b3154
[23] Moayyedi P, Quigley EM, Lacy BE, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. American Journal of Gastroenterology 2014;109(9):1367–1374. 14 trials, 906 patients. Read as its published abstract: the Internet Archive holds neither of the two article addresses we tried. Its reference list, read in Europe PMC’s record, includes the Dutch IBS trial; its table of included trials was not read. Its funding statement was not read. doi:10.1038/ajg.2014.195
[24] de Vries J, Birkett A, Hulshof T, Verbeke K, Gibes K. Effects of cereal, fruit and vegetable fibers on human fecal weight and transit time: a comprehensive review of intervention trials. Nutrients 2016;8(3):130. Studies in healthy people, 4 to 81 per study. Read in full on PubMed Central. Sponsored by a breakfast-cereal maker, which employed three of its five authors; a fourth consults for food companies including that one, and the fifth holds a chair the company endowed. doi:10.3390/nu8030130
[25] Giotaki E, Perri V, Vaughan NJ, et al. Nutritional and phytochemical characterization of commercially available chia, quinoa, pumpkin seed, flaxseed and triticale products. Plants (Basel) 2026;15(13):2079. A university nutrition institute’s laboratory analysis. Read in full on PubMed Central; the values in its fibre chart, an image, were not read. Funded by the Scottish Government’s rural and environmental research programme; the authors declare no conflicts. doi:10.3390/plants15132079
[26] Trial registration NCT04829760, ClinicalTrials.gov: “The effect of psyllium and wheat bran on body weight in people with Parkinson’s disease and constipation symptoms”. Sponsored by a US university. 35 enrolled; psyllium, coarse wheat bran or maltodextrin, 10 g a day for eight weeks; primary outcome body weight, with stool frequency and consistency among the secondary outcomes; completed 28 April 2024; no results posted. Read through the registry’s public data service on 20 October 2026. A registry record; no DOI.
[27] The desk’s searches, 20 October 2026, for the one absence sentence on this page, that we found no published report of the Parkinson’s trial’s results ([26]): PubMed by title and abstract for psyllium or ispaghula with bran and Parkinson’s (0 records), for fibre, Parkinson’s, constipation and randomised trials from 2023 (3 records, every title read) and for the trial’s number (0); Europe PMC for the trial’s number (2 records, both reviews citing the registration) and in two wider wordings (42 and 28 records, titles read); the registry record, which shows no results; and an ordinary web search, its first results read. For the wider wish, a three-arm trial in ordinary chronic constipation: PubMed in three wordings (27, 5 and 9 records, every title read), the registry (4, 20, 2 and 2 records), the 2022 pooling’s table of 16 trials and both guidelines; the newest review’s table could not be read. The record is kept with this page.
[28] McRorie JW Jr, Fahey GC Jr, Gibb RD, Chey WD. Laxative effects of wheat bran and psyllium: resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation. Journal of the American Association of Nurse Practitioners 2020;32(1):15–23. A review. Two of its four authors work for the maker of a psyllium laxative, by their listed affiliation; the other two give US universities, and one of those two is a joint first author of the 2023 US guideline. Read as its published abstract; its funding statement was not read. doi:10.1097/JXX.0000000000000346